Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue engineered small-diameter vascular grafts.

Rachael H Schmedlen1, Wafa M Elbjeirami, Andrea S Gobin

  • 1Department of Bioengineering, Rice University, 6100 Main Street, MS 142 Houston, TX 77005-1892, USA.

Clinics in Plastic Surgery
|November 19, 2003
PubMed
Summary

Tissue engineered vascular grafts (TEVGs) offer a promising solution for vascular reconstructive surgery. Current challenges include long development times, mechanical properties, and immune responses, but future TEVGs aim for clinical viability.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydrogel biomaterials to support and guide vascularization.

Progress in biomedical engineering (Bristol, England)·2025
Same author

Considerations to Better Meet the Needs of People Living With Diabetes While in Prison or Detention.

Diabetes spectrum : a publication of the American Diabetes Association·2024
Same author

A Pragmatic Rethinking of Glucose Monitoring for the Incarcerated.

Diabetes spectrum : a publication of the American Diabetes Association·2024
Same author

Detection of fluorescent protein mechanical switching in cellulo.

Cell reports methods·2024
Same author

Neurogenic Cell Behavior in 3D Culture Enhanced Within a Highly Compliant Synthetic Hydrogel Platform Formed via Competitive Crosslinking.

Cellular and molecular bioengineering·2024
Same author

Antibiotic exposure is associated with decreased risk of psychiatric disorders.

Frontiers in pharmacology·2024

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Vascular Surgery

Background:

  • Arterial occlusive disease is a leading cause of mortality, necessitating vascular reconstructive surgery.
  • Limited availability of small-diameter vascular grafts drives research into tissue-engineered blood vessel substitutes (TEVBs).
  • Current TEVB approaches utilize natural or synthetic scaffolds, with efforts focused on optimizing culture environments for ECM synthesis.

Purpose of the Study:

  • To review the progress, challenges, and future directions in the development of tissue-engineered vascular grafts (TEVGs).
  • To highlight key areas requiring advancement for clinical translation of TEVGs.

Main Methods:

  • Review of existing literature on TEVG development, including scaffold types, culture conditions, and bioreactor applications.

Related Experiment Videos

  • Analysis of challenges related to thrombosis prevention, mechanical properties, culture time, immunogenicity, and clinical applicability.
  • Exploration of future TEVG characteristics, including self-renewal, remodeling, and vasoactivity.

    • Main Results:

    • Significant progress has been made in TEVG development over the past two decades.
    • Key challenges remain, including achieving non-thrombogenic surfaces, adequate mechanical strength, and reduced culture times (typically >8 weeks).
    • Autologous tissues are often required to prevent immune responses, limiting immediate clinical use.

    Conclusions:

    • Despite obstacles, TEVGs hold immense potential for treating vascular disease.
    • Future TEVGs are expected to be non-thrombogenic, possess sufficient mechanical strength for clinical trials, and mimic native vessel properties.
    • Advanced TEVGs may become living grafts capable of growth and remodeling, improving patient quality of life.